The loss of METTL3 inhibits YTHDF1-mediated SPRED2 translation and further enhances the activation of NF-kB and STAT3 through the ERK pathway, ultimately mediating tumor growth and metastasis. This evidence concerns the gene METTL3 and neoplasm.